Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU)

NCT00436345 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

39

Enrollment

INDUSTRY

Sponsor class

Stopped recruitment issues

Conditions

Analgesia

Interventions

DRUG: Remifentanil
DRUG: Propofol

Sponsor

GlaxoSmithKline